A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

October 3, 2022

Study Completion Date

October 3, 2022

Conditions
Genitourinary Syndrome of Menopause (GSM)
Interventions
DEVICE

Revaree

Hyaluronic Acid Vaginal Insert (Revaree). A 2g vaginal insert that contains 5mg of HLA sodium salt and a base of semi-synthetic glycerides. It is an insert that does not require an applicator and should be placed in the vagina while laying down twice weekly.

DRUG

Estrace

Vaginal estrogen cream, estradiol: 100mcg

Trial Locations (1)

10016

NYU Langone Health, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

JDS Therapeutics, LLC

INDUSTRY

lead

NYU Langone Health

OTHER